Posted on 12/11/2015
Speaking at the Asian Society for Vascular Surgery meeting (5–7 September, Hong Kong, China), Andrew Holden (associate professor of Radiology, Auckland City Hospital, Auckland, New Zealand) commented that studies indicate that bioresorbable scaffolds can produce comparable acute results to metal stents for the management of peripheral artery disease. He added that “resorption without restenosis” remained a challenge with these devices but progress had been made.
Holden reported that a bioresorbable scaffold may provide potential benefits over drug-eluting balloons and drug-eluting stents for the management of lesions in lower limbs arteries. He explained that bioresorbable scaffolds, drug-eluting stents, and drug-eluting balloons all provided an “anti-restenosis” strategy, in the form of drug delivery, that he said was required ...